106 related articles for article (PubMed ID: 11557572)
1. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
[TBL] [Abstract][Full Text] [Related]
2. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.
Bajou K; Masson V; Gerard RD; Schmitt PM; Albert V; Praus M; Lund LR; Frandsen TL; Brunner N; Dano K; Fusenig NE; Weidle U; Carmeliet G; Loskutoff D; Collen D; Carmeliet P; Foidart JM; Noël A
J Cell Biol; 2001 Feb; 152(4):777-84. PubMed ID: 11266468
[TBL] [Abstract][Full Text] [Related]
3. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci; 2001 Jun; 21(12):4348-55. PubMed ID: 11404420
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen and plasmin activity in patients with coronary artery disease.
Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
[TBL] [Abstract][Full Text] [Related]
5. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.
Teesalu T; Hinkkanen AE; Vaheri A
Am J Pathol; 2001 Dec; 159(6):2227-37. PubMed ID: 11733372
[TBL] [Abstract][Full Text] [Related]
6. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
[TBL] [Abstract][Full Text] [Related]
7. Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia.
Lupu C; Herlea O; Tang H; Lijnen RH; Lupu F
J Thromb Haemost; 2013 Jan; 11(1):142-8. PubMed ID: 23106863
[TBL] [Abstract][Full Text] [Related]
8. The role of plasminogen in angiogenesis in vivo.
Oh CW; Hoover-Plow J; Plow EF
J Thromb Haemost; 2003 Aug; 1(8):1683-7. PubMed ID: 12911578
[TBL] [Abstract][Full Text] [Related]
9. Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain.
Hultman K; Cortes-Canteli M; Bounoutas A; Richards AT; Strickland S; Norris EH
J Thromb Haemost; 2014 May; 12(5):701-12. PubMed ID: 24612416
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels.
Vieira ML; Alvarez-Flores MP; Kirchgatter K; Romero EC; Alves IJ; de Morais ZM; Vasconcellos SA; Chudzinski-Tavassi AM; Nascimento AL
Infect Immun; 2013 May; 81(5):1764-74. PubMed ID: 23478319
[TBL] [Abstract][Full Text] [Related]
11. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
12. Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis.
Jurasz P; Santos-Martinez MJ; Radomska A; Radomski MW
J Thromb Haemost; 2006 May; 4(5):1095-106. PubMed ID: 16689764
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 is a critical regulator of FGF23 homeostasis.
Eren M; Place AT; Thomas PM; Flevaris P; Miyata T; Vaughan DE
Sci Adv; 2017 Sep; 3(9):e1603259. PubMed ID: 28924605
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction.
Sillen M; Weeks SD; Zhou X; Komissarov AA; Florova G; Idell S; Strelkov SV; Declerck PJ
J Thromb Haemost; 2020 Mar; 18(3):681-692. PubMed ID: 31858714
[TBL] [Abstract][Full Text] [Related]
15. Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function.
Fang H; Placencio VR; DeClerck YA
J Natl Cancer Inst; 2012 Oct; 104(19):1470-84. PubMed ID: 22984202
[TBL] [Abstract][Full Text] [Related]
16. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.
Hattori N; Mizuno S; Yoshida Y; Chin K; Mishima M; Sisson TH; Simon RH; Nakamura T; Miyake M
Am J Pathol; 2004 Mar; 164(3):1091-8. PubMed ID: 14982862
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 is involved in glucocorticoid-induced decreases in angiogenesis during bone repair in mice.
Okada K; Niwa Y; Fukuhara K; Ohira T; Mizukami Y; Kawao N; Matsuo O; Kaji H
J Bone Miner Metab; 2024 May; 42(3):282-289. PubMed ID: 38704516
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
Kremen M; Krishnan R; Emery I; Hu JH; Slezicki KI; Wu A; Qian K; Du L; Plawman A; Stempien-Otero A; Dichek DA
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17109-14. PubMed ID: 18957535
[TBL] [Abstract][Full Text] [Related]
19. Transgenic Anopheles mosquitoes expressing human PAI-1 impair malaria transmission.
Pascini TV; Jeong YJ; Huang W; Pala ZR; Sá JM; Wells MB; Kizito C; Sweeney B; Alves E Silva TL; Andrew DJ; Jacobs-Lorena M; Vega-Rodríguez J
Nat Commun; 2022 May; 13(1):2949. PubMed ID: 35618711
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans.
Iwaki T; Tanaka A; Miyawaki Y; Suzuki A; Kobayashi T; Takamatsu J; Matsushita T; Umemura K; Urano T; Kojima T; Terao T; Kanayama N
J Thromb Haemost; 2011 Jun; 9(6):1200-6. PubMed ID: 21486382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
